Cargando…

Unravelling the epidemiology of late-onset and asymptomatic carriers of FAP ATTR V30M in a Portuguese population

Detalles Bibliográficos
Autores principales:	Lemos, Carolina, Coelho, Teresa, Alves-Ferreira, Miguel, Santos, Diana, Sequeiros, Jorge, Sousa, Alda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642133/ http://dx.doi.org/10.1186/1750-1172-10-S1-O3

Ejemplares similares

The hidden story behind gender differences in familial amyloid polyneuropathy (FAP) ATTRV30M
por: Santos, Diana, et al.
Publicado: (2015)

Specific ophtalmologic changes in late onset familial amyloid polyneuropathy (FAP) portuguese patients
por: Ferreira, Natalia, et al.
Publicado: (2015)

Diflunisal in late-onset FAP patients with moderate to severe neuropathy
por: Obici, Laura, et al.
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Comparison of MIBG and Diphosphonate scintigraphy in cardiac involvement of aTTR-FAP
por: Chequer, Renata, et al.
Publicado: (2015)

ATTR-FAP: liver transplantation vs oral medication, how and when
por: Erikzon, Bo Goran
Publicado: (2015)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases
por: Beirão, João Melo, et al.
Publicado: (2015)

Familial amyloid polyneuropathy in Portugal: New genes modulating age‐at‐onset
por: Santos, Diana, et al.
Publicado: (2016)

C1QA and C1QC modify age‐at‐onset in familial amyloid polyneuropathy patients
por: Dias, Andreia, et al.
Publicado: (2019)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

Multi-modality imaging in cardiac ATTR amyloidosis: agreement between echocardiography, MRI and DPD-scintigraphy
por: Eliahou, Ludivine, et al.
Publicado: (2015)

Mutation-negative FAP patients with mRNA defects of APC
por: Condie, Michelle W, et al.
Publicado: (2010)

TUDCA as an autophagic modulator of ATTR V30M Amyloidosis
por: Teixeira, Cristina, et al.
Publicado: (2015)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

HTLV-1 world distribution and estimation of the number of asymptomatic infected carriers
por: Gessain, Antoine, et al.
Publicado: (2014)

TTR-FAP: a single-center experience in Sicily, an Italian endemic area
por: Mazzeo, Anna, et al.
Publicado: (2015)

Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin Variant
por: Aono, Yuya, et al.
Publicado: (2020)

Specific ocular changes in TTR Met30-FAP after liver transplantation
por: Ferreira, Natalia, et al.
Publicado: (2015)

Neurophysiological pitfalls in TTR-FAP Val30Met
por: Conceição, Isabel, et al.
Publicado: (2015)

Positron Emission Tomography (PET) utilizing Pittsburgh compound B (PIB) detects amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
por: Pilebro, Björn, et al.
Publicado: (2015)

Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy
por: Lopes, Alice, et al.
Publicado: (2017)

Unraveling a rare cause of spinal stenosis: Coexistent AL and ATTR amyloidosis involving the ligamentum flavum
por: Godara, Amandeep, et al.
Publicado: (2022)

Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: a comparison between late- and early-onset disease
por: Raya-Cruz, Manuel, et al.
Publicado: (2015)

Unraveling migraine susceptibility in females: the involvement of GABA genes
por: Quintas, MS, et al.
Publicado: (2013)

Imaging cardiac ATTR amyloid
por: Hawkins, Philip N
Publicado: (2015)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP)
por: Adams, David, et al.
Publicado: (2015)

Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1
por: Manuel, Sharrón L, et al.
Publicado: (2014)

Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013)

An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T-cell leukemia virus type 1
por: Manuel, Sharrón L, et al.
Publicado: (2014)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

ATTR Epidemiology, Genetics, and Prognostic Factors
por: Obi, Chukwuemeka A., et al.
Publicado: (2022)

Diagnosis and Treatment of AL and ATTR Amyloidosis
por: Faiman, Beth, et al.
Publicado: (2021)

Patients with hereditary ATTR amyloidosis experience an increasing burden of illness as the disease progresses
por: Adams, David, et al.
Publicado: (2015)

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy
por: Adams, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jk01nvancr6klpb7j93skpps4o